Title : Targeting both BET and CBP/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti-tumor activity in multiple myeloma.

Pub. Date : 2021 Jan

PMID : 32997383






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Targeting both BET and CBP/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti-tumor activity in Multiple Myeloma. HLA-B*27:34 antigen E1A binding protein p300 Homo sapiens
2 Here we present the first data exploring the anti-tumor activity of two novel dual inhibitors, NEO2734 and NEO1132, of both BET and CBP/EP300 proteins in MM. HLA-B*27:34 antigen E1A binding protein p300 Homo sapiens